ARCHIVES

Wyden Asks Healy To Clarify CRADA Pricing Clause

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

Americans Shouldn’t Take NIH for Granted, Healy Tells NCAB

May 24, 1991

NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate

October 22, 1993

Upton Struggling To wrap Up Reorganization Of DCCR Before Next Week’s Meeting Of NCAB

September 28, 1979

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

Niccotine Reports As Aiding Metastasis

August 22, 1986